Melissa Brown
Psychiatric/Mental Health · Greenville, SCNPI 1568178713
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) accounts for 61.9% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $12,187, more than ten times the $986 reported in 2023. Among psychiatric/mental health clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $59.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$10K
- Neurocrine Biosciences, Inc.$2K
- Axsome Therapeutics, Inc.$833
- AbbVie$743
- Otsuka America Pharmaceutical, Inc.$650
- Vanda Pharmaceuticals Inc.$327
- plus $2K from 17 others
What the payments were for
- Consulting fees$4,00026%
- Speaking & faculty fees$5,00032%
- Travel & lodging$3102%
- Food & beverage$6,23940%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 64 | $9,633 |
| Neurocrine Biosciences, Inc. | 9 | $1,781 |
| Axsome Therapeutics, Inc. | 26 | $833 |
| AbbVie | 42 | $743 |
| Otsuka America Pharmaceutical, Inc. | 32 | $650 |
| Vanda Pharmaceuticals Inc. | 17 | $327 |
| Johnson & Johnson | 11 | $281 |
| Lundbeck LLC | 13 | $234 |
| E.r. Squibb & Sons, L.L.C. | 5 | $182 |
| Alkermes, Inc. | 7 | $147 |
| Ironshore Pharmaceuticals Inc. | 5 | $135 |
| Idorsia Pharmaceuticals US Inc | 2 | $109 |
| Teva Pharmaceuticals USA, Inc. | 5 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
| Almatica Pharma LLC | 4 | $68 |
| Noven Therapeutics, LLC | 3 | $61 |
| Tris Pharma Inc | 3 | $52 |
| Biogen | 2 | $36 |
| Bausch Health US, LLC | 2 | $36 |
| Sage Therapeutics, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Corium, LLC | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,561 in reported general payments places this provider in the 95th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 29 | $48,926 |
| VraylarCariprazine Hcl | 18 | $25,199 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $1,369 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $826 |
| Ramelteon | 14 | $446 |
| Gabapentin | 19 | $336 |
| Amitriptyline Hcl | 19 | $179 |
| Clonazepam | 25 | $95 |
| Trazodone Hcl | 18 | $94 |
| Alprazolam | 21 | $89 |
| Lamotrigine | 15 | $66 |
| Diazepam | 22 | $65 |
| Buspirone Hcl | 12 | $45 |
| Fluoxetine Hcl | 11 | $39 |
| Sertraline Hcl | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $650 | $48,92629 claims |
| AbbVieVraylar | $743 | $25,19918 claims |
| Almatica Pharma LLCSertraline Hcl | $68 | $3811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Greenville
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Lauren DyerGreenville$16K
- William HendricksGreenville$13K
- Carrie BallengerGreenville$11K
- Gregory SmithGreenville$9K
- Svetlana RobinsonGreenville$8K
- Jared CarboneGreenville$7K
- Anglique RichGreenville$6K
- Matthew HendricksGreenville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.